Canonical: https://ownershiptrace.com/13f/companies/4655

# Who owns Eledon Pharmaceuticals, Inc. (ELDN)? Elite investor 13F holders

2 tracked elite investors reported holding Eledon Pharmaceuticals, Inc as of 2026-06-30, including 22NW Fund, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [22NW Fund](https://ownershiptrace.com/13f/investors/118) | ELEDON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2507274.00 USD | 636364.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1694297/0001214659-26-010406-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ELEDON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 791546.00 USD | 200900.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)